Advisory Committees
-
July 26-27, 2010: Blood Products Advisory Committee Meeting Presentations
-
FDA Presentations
Persons with disabilities having problems accessing the PowerPoint documents may call 301-827-0314 for assistance.
- July 26, 2010: Blood Products Advisory Committee Meeting Presentation: FDA EID Workshop: Day 2 Organs, Tissues and Cells (PPT - 1.8MB)
Melissa A. Greenwald, MD July 27, 2010: Blood Products Advisory Committee Meeting: Hemoglobin/Hematocrit Acceptance Standards and Interdonation Interval in Blood Donors (PPT - 625KB)
Orieji Illoh, MDJuly 27, 2010: Blood Products Advisory Committee Meeting Presentation: Hemoglobin/Hematocrit Acceptance Standards and Interdonation Interval in Blood Donors (PPT - 308KB)July 26, 2010: Blood Products Advisory Committee Meeting Presentation: Xenotropic Murine Leukemia Virus Related Virus (XMRV) Informational Presentation (PPT - 227KB)
Indira Hewlett, Ph. D- July 26, 2010: Blood Products Advisory Committee Meeting Presentation: An Update on FDA/OBRR XMRV Activities (PPT - 543KB)
Indira Hewlett, Ph.D - July 26, 2010: Blood Products Advisory Committee Meeting Presentation: Babesia BPAC: FDA Perspective (PPT - 290KB)
Sanjai Kumar, PhD July 26, 2010: Blood Products Advisory Committee Meeting Presentation: Risk of Babesia Infection by Blood Transfusion and Potential Strategies for Donor Testing: Introduction (PPT - 1MB)
Sanjai Kumar, PhDJuly 26-27, 2010: Blood Products Advisory Committee Meeting Presentation: HHS Secretary’s Advisory Committee on Blood Safety and Availability (PPT - 395KB)
Jerry A. Holmberg, Ph.D.July 26-27, 2010: Blood Products Advisory Committee Meeting Presentation: Transfusion Transmitted Babesiosis Risk Assessment (PPT - 121KB)
Mark Walderhaug, Mikhail Menis, David King, Richard ForsheeJuly 27, 2010: Blood Products Advisory Committee Meeting Presentation: FDA Workshop on “Emerging Infectious Diseases: Evaluation to Implementation for Transfusion and Transplantation Safety” (PPT - 73KB)
Paul A. Mied, Ph.D.July 27, 2010: Blood Products Advisory Committee Meeting Presentation: Update on Q Fever Epidemic in the Netherlands and US Public Health Response (PPT - 3.6MB)
Hira Nakhasi, Ph.D.
-
-
Sponsor
Persons with disabilities having problems accessing the documents may call 301-827-0314 for assistance.
July 26-27, 2010: Blood Products Advisory Committee Presenation: Predicting Iron Deficiency in Blood Donors (PPTX - 391KB)
Ritchard G. Cable, Simone A. Glynn, Joseph E. Kiss, Alan E. Mast, Whitney R. Steele, Edward L. Murphy, David J. Wright, Ronald A. Sacher, Jerry L. Gottschall, Vibha Vij, Toby L. SimonJuly 26-27, 2010: Blood Products Advisory Committee Meeting Presentation: Iron Status in Blood Donors (PPT - 1.1MB)
Barbara J. Bryant, MDJuly 26, 2010: Blood Products Advisory Committee Meeting Presentation: Update on CDC XMRV Activities (PPTX - 9.4MB)
R. Michael Hendry, D.Sc.July 26-27, 2010: Blood Products Advisory Committee Meeting Presentation: Identification of the New Human Retrovirus XMRV (PPT - 9.5MB)
SilvermanJuly 26-27, 2010: Blood Products Advisory Committee Presentation: Strategies for Managing Potential Xenotropic Murine Virus Related Virus (XMRV) Threats to Blood Safety: A Health Canada Perspective (PPT - 466KB)
Dr. Peter R. GanzJuly 26-27, 2010: Blood Products Advisory Committee Meeting Presentation: Xenotropic Murine Leukemia Virus-Related Retrovirus: CCR Assay Development (PPT - 9.8MB)
LeGriceJuly 26-27, 2010: Blood Products Advisory Committee Meeting Presentation: Emerging Arboviruses: Evaluating the Threat to Transfusion and Transplantation Safety (PPT - 1.3MB)
Maria Rios and Deborah TaylorJuly 26-27, 2010: Blood Products Advisory Committee Meeting Presentation: Epidemiology of Babesiosis, including Transfusion-Associated Infection (PPTX - 8.4MB)
Barbara L. Herwaldt, MD, MPHJuly 26-27, 2010: Blood Products Advisory Committee Meeting Presentation: Experience With Testing Blood Donors for Babesia (PPT - 1.6MB)
David A. Leiby, PhD- July 27, 2010: Blood Products Advisory Committee Meeting Presentation: Proposed Changes to Hemoglobin and Donation Interval Criteria for Whole Blood Donors: Projected Impact on Current Donor Basecriteria for whole blood donors: Projected impact on current donor base (PPT - 1.3MB)
Anne Eder, MD PhD July 27, 2010: Blood Products Advisory Committee Meeting Presentation: Blood XMRV Scientific Research Working Group (PPTX - 237KB)
Graham Simmons, Ph.D
-
-
-
